WallStSmart

BWX Technologies Inc (BWXT)vsNorthrop Grumman Corporation (NOC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Northrop Grumman Corporation generates 1212% more annual revenue ($41.95B vs $3.20B). BWXT leads profitability with a 10.3% profit margin vs 10.0%. BWXT appears more attractively valued with a PEG of 1.67. BWXT earns a higher WallStSmart Score of 62/100 (C+).

BWXT

Buy

62

out of 100

Grade: C+

Growth: 8.7Profit: 7.0Value: 4.7Quality: 5.0

NOC

Buy

56

out of 100

Grade: C

Growth: 6.0Profit: 7.5Value: 6.7Quality: 6.0
Piotroski: 3/9Altman Z: 1.96
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BWXTSignificantly Overvalued (-18.5%)

Margin of Safety

-18.5%

Fair Value

$167.54

Current Price

$222.13

$54.59 premium

UndervaluedFair: $167.54Overvalued
NOCUndervalued (+24.9%)

Margin of Safety

+24.9%

Fair Value

$904.35

Current Price

$691.21

$213.14 discount

UndervaluedFair: $904.35Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BWXT3 strengths · Avg: 8.3/10
Return on EquityProfitability
28.5%9/10

Every $100 of equity generates 28 in profit

Revenue GrowthGrowth
18.7%8/10

18.7% revenue growth

EPS GrowthGrowth
31.1%8/10

Earnings expanding 31.1% YoY

NOC3 strengths · Avg: 8.7/10
Market CapQuality
$97.36B9/10

Large-cap with strong market position

Return on EquityProfitability
26.2%9/10

Every $100 of equity generates 26 in profit

Free Cash FlowQuality
$3.23B8/10

Generating 3.2B in free cash flow

Areas to Watch

BWXT3 concerns · Avg: 3.3/10
PEG RatioValuation
1.674/10

Expensive relative to growth rate

Price/BookValuation
16.5x4/10

Trading at 16.5x book value

P/E RatioValuation
57.2x2/10

Premium valuation, high expectations priced in

NOC4 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.964/10

Grey zone — moderate risk

Debt/EquityHealth
1.183/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
5.362/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : BWXT

The strongest argument for BWXT centers on Return on Equity, Revenue Growth, EPS Growth. Revenue growth of 18.7% demonstrates continued momentum.

Bull Case : NOC

The strongest argument for NOC centers on Market Cap, Return on Equity, Free Cash Flow.

Bear Case : BWXT

The primary concerns for BWXT are PEG Ratio, Price/Book, P/E Ratio. A P/E of 57.2x leaves little room for execution misses.

Bear Case : NOC

The primary concerns for NOC are Altman Z-Score, Debt/Equity, Piotroski F-Score.

Key Dynamics to Monitor

BWXT profiles as a growth stock while NOC is a value play — different risk/reward profiles.

BWXT carries more volatility with a beta of 0.81 — expect wider price swings.

BWXT is growing revenue faster at 18.7% — sustainability is the question.

NOC generates stronger free cash flow (3.2B), providing more financial flexibility.

Bottom Line

BWXT scores higher overall (62/100 vs 56/100) and 18.7% revenue growth. NOC offers better value entry with a 24.9% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

BWX Technologies Inc

INDUSTRIALS · AEROSPACE & DEFENSE · USA

BWX Technologies, Inc. manufactures and sells nuclear components in the United States, Canada, and internationally. The company is headquartered in Lynchburg, Virginia.

Northrop Grumman Corporation

INDUSTRIALS · AEROSPACE & DEFENSE · USA

Northrop Grumman Corporation (NYSE: NOC) is an American multinational aerospace and defense technology company.

Visit Website →

Want to dig deeper into these stocks?